首页    期刊浏览 2024年12月04日 星期三
登录注册

文章基本信息

  • 标题:Protective Effect of Edaravone against Cationic Lipid-Mediated Oxidative Stress and Apoptosis
  • 本地全文:下载
  • 作者:Takeshi Terada ; Jayesh A Kulkarni ; Ariel Huynh
  • 期刊名称:Biological and Pharmaceutical Bulletin
  • 印刷版ISSN:0918-6158
  • 电子版ISSN:1347-5215
  • 出版年度:2021
  • 卷号:44
  • 期号:1
  • 页码:144-149
  • DOI:10.1248/bpb.b20-00679
  • 出版社:The Pharmaceutical Society of Japan
  • 摘要:Liposomes containing ionizable cationic lipids have been widely used for the delivery of nucleic acids such as small-interfering RNA and mRNA. The utility of cationic lipids with a permanent positive charge, however, is limited to in vitro transfection of cultured cells due to its dose-limiting toxic side effects observed in animals. Several reports have suggested that the permanently charged cationic lipids induce reactive oxygen species (ROS) and ROS-mediated toxicity in cells. We therefore hypothesized that the concomitant use of ROS inhibitor could reduce toxicity and improve drug efficacy. In this study, suppression of the cationic toxicity was evaluated using an ROS scavenger, edaravone, which is a low-molecular-weight antioxidant drug clinically approved for acute-phase cerebral infarction and amyotrophic lateral sclerosis. Cell viability assay in the mouse macrophage-like cell line RAW264 indicated that the concomitant use of edaravone were not able to suppress the cytotoxicity induced by cationic liposomes comprised of monovalent cationic lipid N -(1-[2,3-dioleyloxy]propyl)- N , N , N -trimethylammonium chloride (DOTMA) over a short period of time. Cationic lipids-induced necrosis was assumed to be involved in the cytotoxicity upon short-term exposure to cationic liposomes. On the other hand, the significant improvement of cell viability was observed when the short treatment with cationic liposomes was followed by exposure to edaravone for 24 h. It was also confirmed that apoptosis inhibition by ROS elimination might have contributed to this effect. These results suggest the utility of continuous administration with edaravone as concomitant drug for suppression of adverse reactions in therapeutic treatment using cationic liposomes.
  • 关键词:liposome;edaravone;cationic lipid;reactive oxygen species
国家哲学社会科学文献中心版权所有